Aprea Therapeutics, Inc. (APRE)
0.695
-0.03
(-3.94%)
USD |
NASDAQ |
Oct 02, 16:00
0.6951
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Market Cap : 8.612M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 8.612M |
| October 01, 2026 | 8.965M |
| September 30, 2026 | 9.293M |
| September 29, 2026 | 9.536M |
| September 28, 2026 | 9.316M |
| September 25, 2026 | 9.427M |
| September 24, 2026 | 9.661M |
| September 23, 2026 | 9.665M |
| September 22, 2026 | 9.075M |
| September 21, 2026 | 9.132M |
| September 18, 2026 | 9.416M |
| September 17, 2026 | 9.293M |
| September 16, 2026 | 9.052M |
| September 15, 2026 | 9.278M |
| September 14, 2026 | 9.682M |
| September 11, 2026 | 9.590M |
| September 10, 2026 | 9.779M |
| September 09, 2026 | 9.806M |
| September 08, 2026 | 10.35M |
| September 04, 2026 | 9.842M |
| September 03, 2026 | 9.991M |
| September 02, 2026 | 10.16M |
| September 01, 2026 | 10.36M |
| August 31, 2026 | 9.913M |
| August 28, 2026 | 10.39M |
| Date | Value |
|---|---|
| August 27, 2026 | 10.66M |
| August 26, 2026 | 12.14M |
| August 25, 2026 | 11.77M |
| August 24, 2026 | 9.977M |
| August 21, 2026 | 7.934M |
| August 20, 2026 | 7.931M |
| August 19, 2026 | 8.314M |
| August 18, 2026 | 8.327M |
| August 17, 2026 | 8.550M |
| August 14, 2026 | 8.425M |
| August 13, 2026 | 8.314M |
| August 12, 2026 | 8.463M |
| August 11, 2026 | 8.179M |
| August 10, 2026 | 7.984M |
| August 07, 2026 | 8.058M |
| August 06, 2026 | 7.579M |
| August 05, 2026 | 7.442M |
| August 04, 2026 | 7.181M |
| August 03, 2026 | 7.162M |
| July 31, 2026 | 7.429M |
| July 30, 2026 | 7.609M |
| July 29, 2026 | 7.441M |
| July 28, 2026 | 7.354M |
| July 27, 2026 | 7.486M |
| July 24, 2026 | 7.573M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zymeworks, Inc. | 1.810B |
| Rhythm Pharmaceuticals, Inc. | 6.388B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
Market Cap Related Metrics
| PS Ratio | 2747.58 |
| Price to Book Value | 0.2239 |
| Price | 0.695 |
| Earnings Yield | -154.9% |